Literature DB >> 19877736

The role of the laboratory in the diagnosis of invasive candidiasis.

Maria Teresa Montagna1, Giuseppina Caggiano, Elisa Borghi, Giulia Morace.   

Abstract

A diagnosis of invasive candidiasis can be achieved using conventional approaches (microscopy, culture, serology), as well as new methods, including antigen detection and polymerase chain reaction (PCR) assays. Most of the conventional approaches lack sensitivity, especially for obtaining a diagnosis of invasive candidiasis in immunocompromised patients. Antigen detection and PCR assays represent a valid alternative, in terms of their high potential sensitivity and specificity, but these procedures still need to be standardized and evaluated in a large number of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877736     DOI: 10.2165/11315630-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  12 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

Review 2.  British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.

Authors:  David W Denning; Christopher C Kibbler; Rosemary A Barnes
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

3.  Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

Review 4.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Trends in species causing fungaemia in a tertiary care medical centre over 12 years.

Authors:  P N Malani; S F Bradley; R S Little; C A Kauffman
Journal:  Mycoses       Date:  2001-12       Impact factor: 4.377

6.  Epidemiology of nosocomial fungal infections.

Authors:  S K Fridkin; W R Jarvis
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

Authors:  M A Pfaller; D J Diekema; M G Rinaldi; R Barnes; B Hu; A V Veselov; N Tiraboschi; E Nagy; D L Gibbs
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

8.  DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Wolfgang Seifarth; Margit Hummel; Oliver Frank; Alice Fabarius; Chun Zheng; Handan Mörz; Rüdiger Hehlmann; Dieter Buchheidt
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

9.  Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.

Authors:  Rana A Hajjeh; Andre N Sofair; Lee H Harrison; G Marshall Lyon; Beth A Arthington-Skaggs; Sara A Mirza; Maureen Phelan; Juliette Morgan; Wendy Lee-Yang; Meral A Ciblak; Lynette E Benjamin; Laurie Thomson Sanza; Sharon Huie; Siew Fah Yeo; Mary E Brandt; David W Warnock
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

View more
  7 in total

1.  Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections.

Authors:  Pasquale De Bellis
Journal:  Drugs       Date:  2009       Impact factor: 9.546

2.  When and how to cover for fungal infections in patients with severe sepsis and septic shock.

Authors:  Nicolas Allou; Jerome Allyn; Philippe Montravers
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

3.  Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.

Authors:  G Lo Cascio; R Koncan; G Stringari; A Russo; A Azzini; A Ugolini; M Ligozzi; E Polati; G Cornaglia; E Concia; V Schweiger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-13       Impact factor: 3.267

4.  Fungal infection in a patient with multiple sclerosis.

Authors:  D Pisa; R Alonso; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

5.  Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.

Authors:  Maria Teresa Montagna; Caterina Coretti; Grazia Lovero; Osvalda De Giglio; Osvaldo Montagna; Nicola Laforgia; Nicola Santoro; Giuseppina Caggiano
Journal:  Int J Mol Sci       Date:  2011-09-14       Impact factor: 5.923

6.  A multiplex nested PCR for the detection and identification of Candida species in blood samples of critically ill paediatric patients.

Authors:  Cleison Ledesma Taira; Thelma Suely Okay; Artur Figueiredo Delgado; Maria Esther Jurfest Rivero Ceccon; Margarete Teresa Gottardo de Almeida; Gilda Maria Barbaro Del Negro
Journal:  BMC Infect Dis       Date:  2014-07-21       Impact factor: 3.090

7.  A novel molecular imprinting polymer for the selective adsorption of D-arabinitol from spiked urine.

Authors:  Yuni Retnaningtyas; Ganden Supriyanto; Ni Nyoman Tri Puspaningsih; Roedi Irawan; Siswandono Siswodihardjo
Journal:  Turk J Chem       Date:  2020-10-26       Impact factor: 1.239

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.